Lv41
690 积分 2023-08-28 加入
Remission of Type 2 Diabetes: User's Guide: Diabetes Canada Clinical Practice Guidelines Expert Working Group
1小时前
已完结
Hypoglycemic Response to Dorzagliatin in a Patient With GCK-MODY
14小时前
已完结
Dorzagliatin for Type 2 Diabetes Mellitus: A Systematic Review and Meta-analysis of Randomized Phase II/III Trials
15小时前
已完结
Understanding weight regain after a nutritional weight loss intervention: Systematic review and meta-analysis
25天前
已完结
Contemporary medical, device, and surgical therapies for obesity in adults
1个月前
已完结
Efficacy and safety of tirzepatide added to basal insulin in patients with type 2 diabetes in China (SURPASS-CN-INS): a double-blind, multicentre, randomised, placebo-controlled, phase 3 trial
1个月前
已完结
Efficacy and safety of tirzepatide added to basal insulin in patients with type 2 diabetes in China (SURPASS-CN-INS): a double-blind, multicentre, randomised, placebo-controlled, phase 3 trial
1个月前
已完结
Disease modifying therapies in diabetes and endocrinology
1个月前
已完结
Efficacy and safety of tirzepatide added to basal insulin in patients with type 2 diabetes in China (SURPASS-CN-INS): a double-blind, multicentre, randomised, placebo-controlled, phase 3 trial
1个月前
已关闭
皖公网安备34019202002308
